Lupus & Connective Tissue Diseases
News
Benlysta approved for children with SLE
This approval marks the first medicine in the United States meant to treat systemic lupus erythematous in children.
Feature
Twitter chat recap: Take-homes from LUPUS 2019
Scores of tweets from a dozen rheumatologists
Feature
Measuring hydroxychloroquine blood levels could inform safe, optimal dosing
SAN FRANCISCO – Debate over appropriate dosing of hydroxychloroquine could be finished if a blood level cut point to prevent retinopathy is...
Conference Coverage
Studies begin to pinpoint ways to diagnose SLE earlier
SAN FRANCISCO – Novel clinical and serologic findings differentiate early SLE from its mimickers.
Video
Gut bacterium R. gnavus linked to lupus flares
Unraveling the mystery of the microbiome and lupus may hold answers.
Conference Coverage
Combo B-cell depletion advances in SLE
SAN FRANCISCO – Double-punch with rituximab/belimumab is now in phase 3 for SLE.
Conference Coverage
Hydroxychloroquine adherence in SLE: worse than you thought
SAN FRANCISCO – Why routinely measuring hydroxychloroquine blood levels matters.
Conference Coverage
‘Type II’ SLE assessment catches what matters to patients
SAN FRANCISCO – Two PGAs at every office visit.
Conference Coverage
Low-dose IL-2 found effective in SLE
SAN FRANCISCO – Lupus nephritis remission occurred in more than half of affected patients.
Latest News
LUPUS 2019 Congress: Top takeaways
Join us at #MDedgeChats on Tuesday, April 23, 2019, at 7:00 pm EST, for a ...
Conference Coverage
Belimumab a bust for black SLE patients
SAN FRANCISCO – Consistently negative yet intriguing results reported in major FDA-mandated postmarketing RCT.